https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53766 Wed 28 Feb 2024 15:55:21 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54297 Wed 28 Feb 2024 15:52:17 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52051 Wed 27 Sep 2023 15:28:59 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:45112 Wed 26 Oct 2022 13:25:03 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:27917 Wed 24 May 2023 11:32:49 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36368 Wed 24 May 2023 11:14:18 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36979 Wed 23 Feb 2022 16:07:36 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36978 Wed 19 Jul 2023 11:51:12 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:39145 N = 389, 16.0 ± 0.4 years, 41.10% female) completed the HIIT-SQ, and factorial validity of the measurement model was explored. Phase 3: Adolescents (N = 100, age 12–14 years, 44% female) completed the HIIT-SQ twice (1 week apart) to evaluate test–retest reliability. Confirmatory factor analysis of the final six items (mean = 3.43–6.73, SD = 0.99–25.30) revealed adequate fit, χ²(21) = 21, p = .01, comparative fit index = .99, Tucker–Lewis index = .99, root mean square of approximation = .07, 90% confidence interval [.04, .11]. Factor loading estimates showed that all items were highly related to the factor (estimates range: 0.81–0.90). Intraclass coefficients and typical error values were .99 (95% confidence interval [.99, 1.00]) and .22, respectively. This study provides preliminary evidence for the validity and reliability of scores derived from the HIIT-SQ in adolescents.]]> Wed 18 May 2022 12:22:41 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:35698 Wed 17 Nov 2021 16:28:24 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48066 Wed 13 Mar 2024 14:02:23 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46073 Wed 13 Mar 2024 13:53:37 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:22740 amount of information provided' (median score=5, "just right"), all aspects of training attained the most positive score of '1'. Pharmacists most valued the integrated team-based approach, GP involvement, and inclusion of real patients, as well as the pre-reading manual, BP measurement workshop, and case studies (simulation). Post-implementation the interviews highlighted that comprehensive training increased pharmacists' confidence in providing the service, however, training of other pharmacy staff and patient recruitment strategies were highlighted as a need in future. Conclusions: Structured, multi-modal training involving simulated and inter-professional learning is effective in preparing selected community pharmacists for the implementation of new services in the context of hypertension management. This training could be further enhanced to prepare pharmacists for the challenges encountered in implementing and evaluating services in practice.]]> Wed 11 Apr 2018 15:01:06 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:1070 Wed 11 Apr 2018 13:58:24 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:5107 Wed 11 Apr 2018 13:35:26 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:4418 Wed 11 Apr 2018 13:31:14 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:26297 Wed 11 Apr 2018 12:51:36 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:31257 Wed 11 Apr 2018 12:20:34 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:30709 p < 0.01). Measures of compliance including serum β-carotene, lycopene and erythrocyte monounsaturated fatty acids were significantly higher in the MedDiet group at three and six months (p < 0.05). Our results indicate that a population of older Australians can adopt a Mediterranean diet over a six month period]]> Wed 11 Apr 2018 11:30:34 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32778 Wed 07 Feb 2024 16:54:46 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50914 Wed 06 Mar 2024 14:16:27 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49749 Tue 30 May 2023 16:18:50 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51395 Tue 13 Feb 2024 10:32:44 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:43857 Tue 04 Oct 2022 12:00:38 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34917 Tue 03 Sep 2019 18:18:26 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34739 50 was as low as 0.2 μM with corresponding MLCs as low as 2.8 μM. This is in contrast to metronidazole which required 24 h to exhibit inhibitory activity. A modified adherence assay, developed for this study, demonstrated that three of the compounds inhibited in vitro adherence of the parasite. The lead compound exhibited rapid giardicidal activity (<5hr). In addition, microscopy studies demonstrated damage to the plasma membrane of trophozoites. In conclusion, a class of aminoguanidines, represented by robenidine, has shown antigiardial activity warranting further investigation.]]> Tue 03 Sep 2019 17:57:16 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:30825 Thu 28 Oct 2021 13:03:53 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:30811 12 weeks post-treatment). Results: Among 93 people treated, 59% had recently injected drugs (past month), 77% were receiving OST and 56% injected drugs during therapy. Overall, 76% completed treatment. Mean on-treatment adherence to PEG-IFN and ribavirin were 98.2% and 94.6%. Overall, 6% of participants missed >1 dose of PEG-IFN and 31% took <95% of their prescribed ribavirin., Higher treatment completion was observed among those receiving 12 vs. 24 weeks of treatment (97% vs. 46%, P < 0.001) while the proportion of participants with 95% on-treatment ribavirin adherence was similar between groups (67% vs. 72%, P = 0.664). Receiving 12 weeks of therapy was independently associated with treatment completion. No factors were associated with 95% RBV adherence. Neither recent injecting drug use at baseline nor during therapy was associated with treatment completion or adherence to ribavirin. In adjusted analysis, treatment completion was associated with SVR (aOR 23.9, 95% CI 2.9–193.8). Conclusions: This study demonstrated a high adherence to directly observed PEG-IFN and self-administered ribavirin among people with ongoing injecting drug use or receiving OST. These data also suggest that shortening therapy from 24 to 12 weeks can lead to improved treatment completion. Treatment completion was associated with improved response to therapy.]]> Thu 28 Oct 2021 13:03:33 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:45307 Thu 27 Oct 2022 13:57:01 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:412 = 6.6 v <= 5.0 mmol/L 1.27 (1.06-1.53); and not ever having had a raised cholesterol 1.20 (1.04-1.40). There was no difference in cardiovascular disease end points and death in those who were and were not initiated on drug therapy at randomization. Conclusions: Failure to initiate antihypertensive therapy for patients at the randomization visit was associated with lower BP measurements, previous drug therapy, younger age, and a historic or current raised cholesterol, but not with overt cardiovascular disease or other risk factors. There was no difference in cardiovascular disease end points and death in those who were and were not initiated on drug therapy at randomization.]]> Thu 25 Jul 2013 09:09:51 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37899 Thu 17 Jun 2021 15:24:15 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36980 Thu 14 Mar 2024 12:34:02 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:28413 Neurourol. Urodynam.]]> Sat 24 Mar 2018 07:35:59 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:22176 Sat 24 Mar 2018 07:14:59 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:23405 Sat 24 Mar 2018 07:13:55 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38817 Mon 29 Jan 2024 18:03:17 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46608 P = 0.76; joint modelling CACE 0.23 [-0.16 to 0.62] P = 0.24; intention-to-treat 0.11 [-0.20 to 0.42] P = 0.49; per protocol 0.29 [-0.07 to 0.65] P = 0.12); results for secondary outcomes and for exploratory analyses were similar. Paracetamol is ineffective for acute LBP even for patients who comply with treatment. This reinforces the notion that management of acute LBP should focus on providing patients advice and reassurance without the addition of paracetamol.]]> Mon 28 Nov 2022 08:58:25 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32258 Mon 23 Sep 2019 13:24:38 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:31894 n=40) and lower back (n=39). No statistically significant associations were observed between consultation type or injury location for either outcome (number of strategies and the length/fraction of time allocated to self-management prescription). Conclusion: Physiotherapists regularly spend time prescribing self-management strategies such as exercise, advice, and the use of heat or ice to patients receiving treatment linked to a range of injury locations. This suggests that self-management is considered to be an important adjunct to in-clinic physiotherapy. The practice implications of this are that clinicians should reflect on how self-management strategies can be used to maximize patient outcomes, and whether the allocation of consultation time to self-management is likely to optimize patient adherence to each strategy.]]> Mon 23 Sep 2019 13:24:28 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32226 Mon 23 Sep 2019 12:51:57 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54770 Mon 11 Mar 2024 15:08:40 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51388 Mon 04 Sep 2023 13:13:02 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:42120 Fri 26 Aug 2022 10:32:20 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36889 5 years) survivors (PE 25%; 95% CI, 14%, 36%). Adherence to multiple behaviours improved over time since 2007. Conclusion: Adherence to physical activity, dietary, and multiple lifestyle behaviours recommendations was low amongst cancer survivors. Recent cancer survivors were relatively more adherent to WCRF/AICR recommendations compared to long-term survivors. Implications for Cancer Survivors: Health promotion programs help support healthy lifestyle behaviours of cancer survivors.]]> Fri 22 Apr 2022 10:24:30 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47247 Fri 16 Dec 2022 12:29:36 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34930 Fri 10 Mar 2023 18:38:15 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:31413 Fri 10 Mar 2023 17:57:35 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49173 Fri 05 May 2023 15:37:24 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52971 Fri 03 Nov 2023 15:31:52 AEDT ]]>